INDV Indivior Plc
- Stocks
- Healthcare
- NASDAQ: INDV
Price (delayed)
$21.05
Market cap
$2.63B
P/E Ratio
21.05
Dividend/share
N/A
EPS
$1
Enterprise value
$2.48B
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline
Highlights
The EPS has soared by 155% YoY
The net income has surged by 152% year-on-year
The equity has plunged by 112% YoY but it has grown by 10% from the previous quarter
Indivior's debt has increased by 30% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: https://www.indivior.com
Key stats
What are the main financial stats of INDV
Market
Valuations
Earnings
Shares outstanding
124.77M
Market cap
$2.63B
Enterprise value
$2.48B
Price to earnings (P/E)
21.05
Price to book (P/B)
N/A
Price to sales (P/S)
2.24
EV/EBIT
9.7
EV/EBITDA
9.51
EV/Sales
2.11
Revenue
$1.17B
Gross profit
$986M
Operating income
$238M
Net income
$128M
EBIT
$256M
EBITDA
$261M
Free cash flow
$142M
Per share
Balance sheet
Liquidity
EPS
$1
EPS diluted
$0.99
Free cash flow per share
$1.14
Book value per share
-$2.06
Revenue per share
$9.39
TBVPS
$11.56
Total assets
$1.45B
Total liabilities
$1.71B
Debt
$366M
Equity
-$257M
Working capital
-$105M
Debt to equity
-1.42
Current ratio
0.9
Quick ratio
0.71
Net debt/EBITDA
-0.55
Margins
Efficiency
Dividend
EBITDA margin
22.2%
Gross margin
84%
Net margin
10.9%
Operating margin
20.3%
Return on assets
9.1%
Return on equity
N/A
Return on invested capital
75.5%
Return on capital employed
64.6%
Return on sales
21.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INDV stock price
How has the Indivior stock price performed over time
Intraday
4.21%
1 week
22.81%
1 month
43.59%
1 year
54.55%
YTD
69.35%
QTD
42.81%
Financial performance
How have Indivior's revenue and profit performed over time
Revenue
$1.17B
Gross profit
$986M
Operating income
$238M
Net income
$128M
Gross margin
84%
Net margin
10.9%
The operating income has surged by 175% year-on-year
INDV's operating margin has surged by 173% year-on-year
The net income has surged by 152% year-on-year
Indivior's net margin has soared by 150% YoY
Price vs fundamentals
How does INDV's price correlate with its fundamentals
Growth
What is Indivior's growth rate over time
Valuation
What is Indivior stock price valuation
P/E
21.05
P/B
N/A
P/S
2.24
EV/EBIT
9.7
EV/EBITDA
9.51
EV/Sales
2.11
The EPS has soared by 155% YoY
The equity has plunged by 112% YoY but it has grown by 10% from the previous quarter
The stock's price to sales (P/S) is 72% more than its last 4 quarters average of 1.3
INDV's revenue is up by 2.4% year-on-year
Efficiency
How efficient is Indivior business performance
The ROS has soared by 188% YoY
Indivior's return on invested capital has surged by 178% YoY
Indivior's ROA has soared by 161% YoY
Dividends
What is INDV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INDV.
Financial health
How did Indivior financials performed over time
Indivior's total assets is 15% lower than its total liabilities
The quick ratio has grown by 16% from the previous quarter and by 13% YoY
The current ratio has grown by 6% YoY and by 2.3% from the previous quarter
The equity has plunged by 112% YoY but it has grown by 10% from the previous quarter
The debt to equity is up by 39% year-on-year but it is down by 9% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.